Employee Benefit Plans (Tables)
|
9 Months Ended |
Sep. 27, 2026 |
|---|
| Employee Benefit and Share-Based Payment Arrangement, Noncash Expense [Abstract] |
|
| Schedule of Shares Available for Grant |
The following table sets forth the available shares for grants as of September 27, 2026:
| | | | | | | Number of Shares | | (In thousands) | Shares available for grants as of December 31, 2025 | 4,409 | | | Additional authorized shares | 4,200 | | | Granted | (6,822) | | | Forfeited / expired / cancelled | 444 | | | | Shares available for grants as of September 27, 2026 | 2,231 | |
|
| Schedule of Stock Option Activity |
Stock option activity during the nine months ended September 27, 2026 was as follows: | | | | | | | | | | | | | Number of Shares | | Weighted Average Exercise Price Per Share | | (In thousands) | | (In dollars) | Outstanding as of December 31, 2025 | 275 | | | $ | 14.10 | | | Granted | — | | | $ | — | | | Exercised | — | | | $ | — | | | Expired / cancelled | — | | | $ | — | | Outstanding as of September 27, 2026 | 275 | | | $ | 14.10 | | Vested and exercisable as of September 27, 2026 | 275 | | | $ | 14.10 | |
|
| Schedule of RSU Activity |
RSU activity, exclusive of PSU activity, during the nine months ended September 27, 2026 was as follows:
| | | | | | | | | | | | | Number of Shares | | Weighted Average Grant Date Fair Value Per Share | | (In thousands) | | (In dollars) | Outstanding as of December 31, 2025 | 6,481 | | | $ | 9.99 | | | Granted | 3,843 | | | $ | 14.06 | | | Vested | (3,681) | | | $ | 11.26 | | | Forfeited / cancelled | (441) | | | $ | 12.32 | | Outstanding as of September 27, 2026 | 6,202 | | | $ | 11.59 | |
|
| Schedule of PSU Activity |
PSU activity during the nine months ended September 27, 2026 was as follows:
| | | | | | | | | | | |
| Number of Shares | | Weighted Average Grant Date Fair Value Per Share | | (In thousands) | | (In dollars) | Outstanding as of December 31, 2025 | 2,970 | | | $ | 10.56 | | | Granted | 2,979 | | | $ | 12.03 | | | Vested | (1,934) | | | $ | 10.29 | | | Forfeited / cancelled | (3) | | | $ | 8.28 | | Outstanding as of September 27, 2026 | 4,012 | | | $ | 11.79 | |
|
| Schedule of Stock-Based Compensation Expense |
The following table sets forth the stock-based compensation expense by line item on the unaudited condensed consolidated statements of operations and comprehensive income:
| | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | September 27,
2026 | | September 28,
2025 | | September 27,
2026 | | September 28,
2025 | | (In thousands) | | Cost of revenue | $ | 1,213 | | | $ | 613 | | | $ | 3,723 | | | $ | 2,615 | | | Research and development | 6,573 | | | 3,752 | | | 20,473 | | | 12,152 | | | Sales and marketing | 2,625 | | | 1,837 | | | 8,696 | | | 6,989 | | | General and administrative | 11,321 | | | 6,936 | | | 30,284 | | | 23,377 | | | Stock-based compensation, net of amounts capitalized | $ | 21,732 | | | $ | 13,138 | | | $ | 63,176 | | | $ | 45,133 | | | Capitalized stock-based compensation | 808 | | | 533 | | | 1,585 | | | 1,402 | | | Total stock-based compensation | $ | 22,540 | | | $ | 13,671 | | | $ | 64,761 | | | $ | 46,535 | |
|